Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1981 in Moderate to Severe COPD
NCT00766415Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of timapiprant in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Nov 2008; status: completed.
02
Drugs
timapiprant
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00766415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00766415.